Heart drug trial aims to protect most vulnerable patients
NCT ID NCT01475123
Summary
This study is testing whether a medication called nicorandil can help prevent serious heart problems in people who have both severe heart disease and kidney failure requiring dialysis. It will involve about 268 patients to see if taking the drug lowers their risk of heart attacks, strokes, or heart-related death. The goal is to see if this treatment can better control their heart disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Kumamoto, 860-8556, Japan
Conditions
Explore the condition pages connected to this study.